Presentation is loading. Please wait.

Presentation is loading. Please wait.

Patterns of care in hilar node-positive (N1) non–small cell lung cancer: A missed treatment opportunity?  Matthew J. Bott, MD, Aalok P. Patel, BS, Vivek.

Published byゆあ こいまる Modified over 5 years ago

Similar presentations

Presentation on theme: "Patterns of care in hilar node-positive (N1) non–small cell lung cancer: A missed treatment opportunity?  Matthew J. Bott, MD, Aalok P. Patel, BS, Vivek."— Presentation transcript:

1 Patterns of care in hilar node-positive (N1) non–small cell lung cancer: A missed treatment opportunity?  Matthew J. Bott, MD, Aalok P. Patel, BS, Vivek Verma, MD, Traves D. Crabtree, MD, Daniel Morgensztern, MD, Clifford G. Robinson, MD, Graham A. Colditz, PhD, Saiama Waqar, MD, Daniel Kreisel, MD, PhD, A. Sasha Krupnick, MD, G. Alexander Patterson, MD, Stephen Broderick, MD, Bryan F. Meyers, MD, Varun Puri, MD, MSCI  The Journal of Thoracic and Cardiovascular Surgery  Volume 151, Issue 6, Pages e2 (June 2016) DOI: /j.jtcvs Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Kaplan-Meier curves for OS in patients with clinical N1-positive NSCLC receiving (A) adequate treatment versus inadequate or no treatment and (B) inadequate treatment versus no treatment (P < .001 for both). Cum, Cumulative; Dx, diagnosis. (See Tables E1 and E2 for 95% confidence intervals and number at risk periodically with time.) The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Kaplan-Meier curve for OS in patients with clinical N1-positive NSCLC undergoing definitive CRT versus those undergoing surgical resection (P < .001). Cum, Cumulative; Dx, diagnosis; CRT, chemoradiation. (See Table E3 for 95% confidence intervals and number at risk periodically with time.) The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 Kaplan-Meier curve for OS in 2308 propensity score–matched patient pairs undergoing either surgical resection or definitive CRT for the treatment of N1 node-positive NSCLC (P < .001). Cum, Cumulative; Dx, diagnosis; CRT, chemoradiation. (See Table E4 for 95% confidence intervals and number at risk periodically with time.) The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

5 Propensity-matched survival for patients undergoing surgery versus CRT for N1-positive NSCLC.
The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Patterns of care in hilar node-positive (N1) non–small cell lung cancer: A missed treatment opportunity?  Matthew J. Bott, MD, Aalok P. Patel, BS, Vivek."

Similar presentations

A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non–small cell lung cancer  Babatunde A. Yerokun, MD, Chi-Fu.

A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non–small cell lung cancer  Babatunde A. Yerokun, MD, Chi-Fu.
The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution  Linda W. Martin, MD, Arlene.

The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution  Linda W. Martin, MD, Arlene.
Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma  Arianna.

Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma  Arianna.
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Local recurrence after surgery for non–small cell lung cancer: A recursive partitioning analysis of multi-institutional data  Chris R. Kelsey, MD, Kristin.

Local recurrence after surgery for non–small cell lung cancer: A recursive partitioning analysis of multi-institutional data  Chris R. Kelsey, MD, Kristin.
Endoscopic Ultrasound for Early Stage Esophageal Adenocarcinoma: Implications for Staging and Survival  Traves D. Crabtree, MD, Wael N. Yacoub, MD, Varun.

Endoscopic Ultrasound for Early Stage Esophageal Adenocarcinoma: Implications for Staging and Survival  Traves D. Crabtree, MD, Wael N. Yacoub, MD, Varun.
Surgical quality of wedge resection affects overall survival in patients with early stage non–small cell lung cancer  Gaurav S. Ajmani, MHS, Chi-Hsiung.

Surgical quality of wedge resection affects overall survival in patients with early stage non–small cell lung cancer  Gaurav S. Ajmani, MHS, Chi-Hsiung.
Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer?  Traves D. Crabtree, MD, Varun Puri,

Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer?  Traves D. Crabtree, MD, Varun Puri,
Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M
Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.
Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC

Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC
Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients  Björn.

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients  Björn.
The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer  Kyong-Ah Yoon,

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer  Kyong-Ah Yoon,
Matthew J. Boyer, MD, PhD, Christina D. Williams, PhD, MPH, David H

Matthew J. Boyer, MD, PhD, Christina D. Williams, PhD, MPH, David H
Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy 

Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy 
Survival after resection of synchronous non–small cell lung cancer

Survival after resection of synchronous non–small cell lung cancer
Joshua E. Rosen, BASc, Michelle C

Joshua E. Rosen, BASc, Michelle C
Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Similar presentations

Ads by Google